Home | Publications | Treatments | Skin care place holder
place holder place holder

Skin care

Medicated Skin Care in Portugal


Publication Date   January 2008
Publisher   Euromonitor International
Product Type   Report
Pages   22
ISBN Number   not applicable
Product Code   EUR848
Ask a question about this product?

Price £450.00

approximately: $777 | €571

Summary


Euromonitor International's Medicated Skin Care in Portugal report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

  • Get a detailed picture of the medicated skin care industry
  • Identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content


OTC Healthcare - South Korea

OTC Healthcare in South Korea : Market Insight

EXECUTIVE SUMMARY
Slowdown in 2006 Increasing health concerns drive sales growth Vitamins and dietary supplements remains the largest product group Rapid growth of Rx industry hinders the growth of OTC Moderate forecast value growth is expected KEY TREND AND DEVELOPMENTS
Rx continues to record faster growth than OTC Wellbeing trend leads to positive sales growth of OTC healthcare Established brands consolidate their positions Declining birth rate affects demand for child-specific OTC healthcare Growing importance of retail grocery channels Growing number of entries leads to fragmentation MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Vitamins & Dietary Supplements Registration and Classification Generics Consumer Expenditure on Health Goods and Medical Services
Table 10 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources

Local Company Profiles - South Korea

Daewoong Pharmaceutical Co Ltd - OTC Healthcare - South Korea
STRATEGIC DIRECTION KEY FACTS
Summary 2 Daewoong Pharmaceutical Co Ltd: Key Facts
Summary 3 Daewoong Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 4 Daewoong Pharmaceutical Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 5 Daewoong Pharmaceutical Co Ltd: Competitive Position 2006
Dong Wha Pharmaceutical Industrial Co Ltd - OTC Healthcare - South Korea
STRATEGIC DIRECTION KEY FACTS
Summary 6 Dong Wha Pharmaceutical Ind. Co Ltd: Key Facts
Summary 7 Dong Wha Pharmaceutical Ind. Co Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 8 Dong Wha Pharmaceutical Ind. Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 9 Dong Wha Pharmaceutical Ind. Co Ltd: Competitive Position 2006
Dong-A Pharmaceutical Co Ltd - OTC Healthcare - South Korea
STRATEGIC DIRECTION KEY FACTS
Summary 10 Dong-A Pharmaceutical Co Ltd: Key Facts
Summary 11 Dong-A Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 12 Dong-A Pharmaceutical Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 13 Dong-A Pharmaceutical Co Ltd: Competitive Position 2006
Korea Ginseng Corp - OTC Healthcare - South Korea
STRATEGIC DIRECTION KEY FACTS
Summary 14 Korea Ginseng Corp: Key Facts
Summary 15 Korea Ginseng Corp: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 16 Korea Ginseng Corp: Production Statistics
COMPETITIVE POSITIONING
Summary 17 Korea Ginseng Corp: Competitive Position 2006
SK Chemicals Co Ltd - OTC Healthcare - South Korea
STRATEGIC DIRECTION KEY FACTS
Summary 18 SK Chemicals Co Ltd: Key Facts
Summary 19 SK Chemicals: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 20 SK Chemicals Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 21 SK Chemicals Co Ltd: Competitive Position 2006

Cough, cold and allergy (hay fever) remedies in South Korea

HEADLINES
TREND
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 12 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 13 Sales of Decongestants by Type: Value 2001-2006
Table 14 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 15 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 16 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 17 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 18 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 19 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 20 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011